Delirium: prevention, diagnosis and management in hospital and long-term care

Equality impact assessment Final (PDF 158 KB)

Committee member list (PDF 126 KB)

Draft guidance consultation

Draft guideline (PDF 192 KB)

Evidence review A (PDF 2.58 MB)

Committee meeting

Minutes 1 (PDF 162 KB)

Stakeholder list updated

Stakeholder list (PDF 119 KB)

Surveillance consultation

Surveillance consultation

Surveillance review proposal (PDF 1.01 MB)

Comments form (MSWord 28 KB)

Review documents

Surveillance review proposal information

Stakeholder list - review proposal

Stakeholder list - review proposal (PDF 191 KB)

Review proposal

Review proposal (PDF 471 KB)

Surveillance review decision

Surveillance review decision (PDF 699 KB)

Other information

Evidence update

Evidence update (PDF 350 KB)

Background information

New NICE guideline set to encourage healthcare professionals to 'think delirium' and take steps to prevent it information

Download the PDF version

2010/103 New NICE guideline set to encourage healthcare professionals to 'think delirium' and take steps to prevent it (PDF 166 KB)

Remit

Remit

Remit (PDF 14 KB)

Stakeholder list and how to register

List of stakeholders

List of stakeholders (PDF 23 KB)

Scoping workshop, consultation and final scope

Scoping workshop, consultation and final scope

Final scope

Final scope (PDF 111 KB)

Stakeholder comments on draft scope

Stakeholder comments on draft scope (PDF 199 KB)

Scope consultation information

Draft scope for consultation

Draft scope for consultation (PDF 119 KB)

Draft scope comments proforma

Draft scope comments proforma (MSWord 48 KB)

List of stakeholders

List of stakeholders (PDF 23 KB)

Guideline development and consultation

Guideline development and consultation

Equalities impact assessment (recommendations)

Equalities impact assessment (recommendations) (PDF 29 KB)

GDG membership list

GDG membership list (PDF 19 KB)

Minutes for GDG meetings

Delirium GDG minutes: 16 July 2009

Delirium GDG minutes: 16 July 2009 (PDF 35 KB)

Delirium GDG minutes: 15 July 2009

Delirium GDG minutes: 15 July 2009 (PDF 35 KB)

Delirium GDG minutes: 22 April 2009

Delirium GDG minutes: 22 April 2009 (PDF 34 KB)

Delirium GDG minutes: 3-4 July 2008

Delirium GDG minutes: 3-4 July 2008 (PDF 38 KB)

Delirium GDG minutes: 13 November 2008

Delirium GDG minutes: 13 November 2008 (PDF 19 KB)

Delirium GDG minutes: 21-22 January 2009

Delirium GDG minutes: 21-22 January 2009 (PDF 20 KB)

Delirium GDG minutes: 4 March 2009

Delirium GDG minutes: 4 March 2009 (PDF 87 KB)

Draft guideline consultation information

Draft full guideline for consultation

Draft full guideline for consultation (PDF 1.85 MB)

Algorithm

Algorithm (PDF 45 KB)

Appendices

Appendices and contents page

Appendices and contents page (PDF 615 KB)

Appendix D adverse effects - included studies

Appendix D adverse effects - included studies (PDF 233 KB)

Appendix D consequences of - included studies

Appendix D consequences of - included studies (PDF 155 KB)

Appendix D diagnostic test accuracy - included studies

Appendix D diagnostic test accuracy - included studies (PDF 182 KB)

Appendix D epidemiology - included studies

Appendix D epidemiology - included studies (PDF 214 KB)

Appendix D non pharmacological risk factors - included studies

Appendix D non pharmacological risk factors - included studies (PDF 90 KB)

Appendix D pharmacological risk factors - included studies

Appendix D pharmacological risk factors - included studies (PDF 49 KB)

Appendix E consequences of cohort studies - methodological quality

Appendix E consequences of cohort studies - methodological quality (PDF 125 KB)

Appendix E diagnostic accuracy tests - methodological quality

Appendix E diagnostic accuracy tests - methodological quality (PDF 172 KB)

Appendix E epidemiology - methodological quality

Appendix E epidemiology - methodological quality (PDF 168 KB)

Appendix E non-pharmacological risk factors cohort studies - methodological quality

Appendix E non-pharmacological risk factors cohort studies - methodological quality (PDF 44 KB)

Appendix E pharmacological risk factors cohort studies - methodological quality

Appendix E pharmacological risk factors cohort studies - methodological quality (PDF 29 KB)

Appendix E patient information - methodological quality

Appendix E patient information - methodological quality (PDF 213 KB)

Appendix F consequences of - multivariate risk factors

Appendix F consequences of - multivariate risk factors (PDF 185 KB)

Appendix F - non-pharmacological risk factors - multivariate risk factors

Appendix F - non-pharmacological risk factors - multivariate risk factors (PDF 293 KB)

Appendix F pharmacological risk factors - multivariate risk factors

Appendix F pharmacological risk factors - multivariate risk factors (PDF 63 KB)

Appendix G diagnostic test accuracy - excluded studies

Appendix G diagnostic test accuracy - excluded studies (PDF 128 KB)

Appendix G adverse effects review - excluded studies

Appendix G adverse effects review - excluded studies (PDF 121 KB)

Appendix G consequences of - excluded studies

Appendix G consequences of - excluded studies (PDF 55 KB)

Appendix G epidemiology review - excluded studies

Appendix G epidemiology review - excluded studies (PDF 146 KB)

Appendix G non-pharmacological risk factors - excluded studies

Appendix G non-pharmacological risk factors - excluded studies (PDF 71 KB)

Appendix G information for patients review - excluded studies

Appendix G information for patients review - excluded studies (PDF 118 KB)

Appendix G pharmacological risk factors - excluded studies

Appendix G pharmacological risk factors - excluded studies (PDF 55 KB)

Appendix G references to excluded studies

Appendix G references to excluded studies (PDF 151 KB)

Appendix K evidence summary - prevention

Appendix K evidence summary - prevention (PDF 34 KB)

Appendix K evidence summary - treatment

Appendix K evidence summary - treatment (PDF 39 KB)

Draft NICE guideline for consultation

Draft NICE guideline for consultation (PDF 250 KB)

Consultation table and with developers responses

Consultation table and with developers responses (PDF 1.02 MB)

List or registered stakeholders information

Published clinical guidelines information

clinical guidelines in development information

Clinical guidelines in development information

Pre-publication check

Pre-publication check information

Pre-publication check - stakeholder comments/developer responses

Pre-publication check - stakeholder comments/developer responses (PDF 49 KB)

Full guideline

Full guideline (PDF 3.5 MB)

Full guideline appendices

Appendix A - Scope

Appendix A - Scope (PDF 64 KB)

Appendix B - Declaration of Interests

Appendix B - Declaration of Interests (PDF 49 KB)

Appendix C - Search Strategies

Appendix C - Search Strategies (PDF 174 KB)

Appendix D - Adverse Effects - Included studies

Appendix D - Adverse Effects - Included studies (PDF 121 KB)

Appendix D - Consequences of - Included studies

Appendix D - Consequences of - Included studies (PDF 155 KB)

Appendix D - Diagnostic Test Accuracy - Included Studies

Appendix D - Diagnostic Test Accuracy - Included Studies (PDF 182 KB)

Appendix D - Epidemiology - Included studies

Appendix D - Epidemiology - Included studies (PDF 91 KB)

Appendix D - Non pharmacological Risk factor - Included studies

Appendix D - Non pharmacological Risk factor - Included studies (PDF 44 KB)

Appendix D - Pharma Nonpharma Prevention Treatment - Included studies

Appendix D - Pharma Nonpharma Prevention Treatment - Included studies (PDF 170 KB)

Appendix D - Pharmacological Risk factors - Included studies

Appendix D - Pharmacological Risk factors - Included studies (PDF 49 KB)

Appendix E - Consequences of

Appendix E - Consequences of (PDF 125 KB)

Appendix E - Diagnostic Accuracy Tests Methodological Quality

Appendix E - Diagnostic Accuracy Tests Methodological Quality (PDF 172 KB)

Appendix E - Epidemiology quality

Appendix E - Epidemiology quality (PDF 71 KB)

Appendix E - Non Pharmacological Risk Factors

Appendix E - Non Pharmacological Risk Factors (PDF 44 KB)

Appendix E - Patient info quality

Appendix E - Patient info quality (PDF 80 KB)

Appendix E - Pharma NonPharma Prevention Treatment

Appendix E - Pharma NonPharma Prevention Treatment (PDF 107 KB)

Appendix E - Pharmacological Risk Factors review - Randomised controlled trials

Appendix E - Pharmacological Risk Factors review - Randomised controlled trials (PDF 23 KB)

Appendix E - Pharmacological Risk Factors review - cohort studies

Appendix E - Pharmacological Risk Factors review - cohort studies (PDF 30 KB)

Appendix G - References for Excluded Studies

Appendix G - References for Excluded Studies (PDF 93 KB)

Appendix H - Recommendations for Future Research

Appendix H - Recommendations for Future Research (PDF 75 KB)

Appendix I - DSM-IV and Scales For Measuring

Appendix I - DSM-IV and Scales For Measuring (PDF 64 KB)

Appendix J - Health Economics

Appendix J - Health Economics (PDF 155 KB)

Appendix K - Forest Plots

Appendix K - Forest Plots (PDF 462 KB)

Full guideline appendices

Consultation table and with developers responses

Consultation table and with developers responses (PDF 1.02 MB)

National Clinical Guideline Centre for Acute and Chronic Conditions